Speech & language rehabilitation
Aphonos is building the next generation of speech and language rehabilitation — AI-powered, deeply personalized, and designed to scale access to therapy for the millions of stroke survivors currently underserved by the system.
The problem
Aphasia — the loss of language ability following a stroke or brain injury — affects more people than Parkinson's disease, cerebral palsy, or muscular dystrophy. Yet most people have never heard of it.
Existing tools either digitise traditional exercises or help patients compensate for lost language. No one has built a system that uses the full capability of modern AI to restore it — personalized to who the patient actually is.
That is what Aphonos is building.
Our approach
Aphonos combines large language model conversational therapy, pre-stroke identity personalization, and a caregiver integration layer into a single platform — built from the ground up for this patient population.
Every session is shaped by who the patient was before their stroke — their career, family, hobbies, and life. This isn't a feature. It's the architecture.
LLM-based conversation adapts in real time to the patient's severity, fatigue, and progress — delivering therapy-grade interaction between clinical sessions.
After every session, families receive a clear summary and actionable guidance. Recovery is a team effort. We built the platform that way from day one.
Our product
Our flagship product is Aphasia.ai: a conversational therapy companion for stroke survivors and their families, available directly to consumers with no clinical referral required.
Phase 1 builds engagement and generates proprietary interaction data. That data de-risks Phase 2 clinical validation — and ultimately the path to a prescription digital therapeutic.
Visit Aphasia.ai →Get in touch
Whether you're an investor, a speech-language therapist, a clinical researcher, or someone who wants to explore a partnership — we'd like to hear from you.
✓ Message sent — we'll be in touch shortly.